Home Featured 2

Featured 2

Featured posts

Random

Korean Lung Cancer Screening Project (K-LUCAS) Led to Launch of New National Lung Cancer Screening Program in Korea

lungcanc

Novel Insights on ctDNA Dynamics During Targeted Therapy and Immune Checkpoint Blockage in NSCLC

The Changing the Landscape of Tobacco Products: Potential Effects of ENDS and HTPs

Artificial Intelligence in Lung Cancer: Opening New Avenues for Detection, Diagnosis, and Prognostication

Liquid Biopsy’s Role in Marker Identification: An Interview With Dr. Martin Filipits

Pembrolizumab Considered for Second Tissue-Agnostic Cancer Indication

lungcanc

Sublobar Resections for Early Lung Cancer

lungcanc

Doctor of Nursing Practice Project Aims to Educate Non-Oncology Providers About...

lungcanc

Nuances of PET Interpretation in Thoracic Oncology: More Than Just Lung...

lungcanc

Timing of Immune Checkpoint Inhibitors With Respect to Molecular Testing in...

lungcanc

Ki-67 in Pulmonary Neuroendocrine Tumors: Where Do We Stand?

lungcanc

Can E-Cigarettes Help Patients Stop Smoking Combustible Cigarettes?

lungcanc

TTFields in Unresectable MPM: STELLAR Results in Practice

lungcanc

The IASLC and the International Thoracic Oncology Nursing Forum: Celebrating Collaboration

lungcanc

Brain Metastases in NSCLC: Is Delaying Upfront Radiation a Viable Option?

lungcanc

12 3...7 Page 1 of 7

Meeting News

Leora Horn, MD – IASLC Virtual Presidential Symposium Presentation

Paul Baas, MD – IASLC Virtual Presidential Symposium Presentation

TRACERx Data Show That Tracking MRD With ctDNA Heralds Disease Relapse

cfDNA Analysis Suggests EML4-ALK Variant Does Not Influence Response to Lorlatinib